Since vaccines don’t cause autism, microdosing them simply means more visits to the doctor, more injections for the child, and a longer period of vulnerability.
Nothing about this makes any sense.
Trump: "We're also going to be demanding the drug companies, with respect to a certain situation -- the autism -- that they make their doses in 20% shots. So you have shot 1, shot 2, shot 3, shot 4, shot 5 ... I think you're gonna see a massive reduction in autism"
Sep 19, 2026 · 2:25 PM UTC
to be extra safe, we should just go with 100 shots of 1% of the dose. Makes as much sense as anything that fat orange tub of goo ”demands”
Let's get some proper scientific data for this new schedule. Then everyone should see a more clear path. There is ZERO scientific evidence that this new schedule WON'T help. Science should never close the door on research. Scared to try something new?
Until you learn none of the vaccines have been double blind placebo studied individually or combined
The vast majority have no idea what they’re talking about
Life is a tradeoff - even traveling to the Dr for additional doses will result in incremental deaths.
Having said that, the policy we recently abrogated where we only give vaccines to children when we can show a strong, predictable benefit should be brought back.
In the 1960s, studies using Kanner’s narrow criteria for classic “infantile autism” typically found 0.4–0.5 cases per 1,000 children (4–5 per 10,000, or about 1 in 2,000–2,500). The best-known example is Lotter’s 1966 Middlesex survey (4.5 per 10,000). A large U.S. administrative study from the same era reported an even lower 0.7 per 10,000. These figures captured only the most severe, classic presentation.
By the 2020s, the measured rate is far higher. The CDC’s ADDM Network (2022 surveillance of 8-year-olds across 16 U.S. sites, reported in 2025) found 32.2 per 1,000 (3.2%, or 1 in 31). Site-level rates ranged from about 1 in 103 to 1 in 19. Earlier ADDM snapshots were 1 in 36 (2020 data) and 1 in 44 (2018 data). Global estimates for recent years cluster around 1% in high-income child surveys and roughly 0.8% age-standardized in the 2021 Global Burden of Disease analysis.
That is a roughly 60- to 80-fold increase in identified prevalence when the 1960s numbers are compared directly with current U.S. child figures













